vs
Side-by-side financial comparison of Maison Solutions Inc. (MSS) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $18.3M, roughly 1.5× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -18.0%, a 15.0% gap on every dollar of revenue. On growth, Maison Solutions Inc. posted the faster year-over-year revenue change (-10.9% vs -25.6%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs -10.1%).
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
MSS vs RMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $18.3M |
| Net Profit | $-5.0M | $-554.0K |
| Gross Margin | 23.4% | 21.1% |
| Operating Margin | -4.9% | -2.2% |
| Net Margin | -18.0% | -3.0% |
| Revenue YoY | -10.9% | -25.6% |
| Net Profit YoY | -1840.5% | 26.7% |
| EPS (diluted) | $-0.23 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $27.6M | $18.3M | ||
| Q3 25 | $27.2M | $15.9M | ||
| Q2 25 | $34.4M | $16.1M | ||
| Q1 25 | $32.3M | $18.9M | ||
| Q4 24 | $29.4M | $24.7M | ||
| Q3 24 | $28.2M | $28.3M | ||
| Q2 24 | $16.9M | $25.8M | ||
| Q1 24 | $13.6M | $22.7M |
| Q4 25 | $-5.0M | $-554.0K | ||
| Q3 25 | $-1.5M | $-1.8M | ||
| Q2 25 | $-287.4K | $-1.5M | ||
| Q1 25 | $1.0M | $-1.5M | ||
| Q4 24 | $-256.0K | $-756.0K | ||
| Q3 24 | $700.9K | $1.7M | ||
| Q2 24 | $-2.8M | $343.0K | ||
| Q1 24 | $-549.0K | $-1.7M |
| Q4 25 | 23.4% | 21.1% | ||
| Q3 25 | 24.1% | 14.3% | ||
| Q2 25 | 9.5% | 15.6% | ||
| Q1 25 | 21.8% | 16.1% | ||
| Q4 24 | 26.9% | 14.7% | ||
| Q3 24 | 28.9% | 22.0% | ||
| Q2 24 | 13.0% | 17.6% | ||
| Q1 24 | 23.4% | 13.5% |
| Q4 25 | -4.9% | -2.2% | ||
| Q3 25 | 0.7% | -9.9% | ||
| Q2 25 | -15.9% | -8.4% | ||
| Q1 25 | 3.7% | -7.2% | ||
| Q4 24 | 3.2% | -2.1% | ||
| Q3 24 | 7.3% | 6.8% | ||
| Q2 24 | -14.4% | 2.0% | ||
| Q1 24 | -2.3% | -5.8% |
| Q4 25 | -18.0% | -3.0% | ||
| Q3 25 | -5.7% | -11.0% | ||
| Q2 25 | -0.8% | -9.3% | ||
| Q1 25 | 3.1% | -8.0% | ||
| Q4 24 | -0.9% | -3.1% | ||
| Q3 24 | 2.5% | 5.9% | ||
| Q2 24 | -16.4% | 1.3% | ||
| Q1 24 | -4.0% | -7.6% |
| Q4 25 | $-0.23 | $-0.01 | ||
| Q3 25 | $-0.08 | $-0.05 | ||
| Q2 25 | $-0.02 | $-0.05 | ||
| Q1 25 | $0.06 | $-0.04 | ||
| Q4 24 | $-0.01 | $-0.02 | ||
| Q3 24 | $0.04 | $0.04 | ||
| Q2 24 | $-0.16 | $0.01 | ||
| Q1 24 | $-0.03 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | $2.6M | — |
| Stockholders' EquityBook value | $11.6M | $37.0M |
| Total Assets | $75.4M | $57.1M |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | $1.1M | $13.6M | ||
| Q2 25 | $775.4K | $12.5M | ||
| Q1 25 | $445.4K | $11.4M | ||
| Q4 24 | $355.7K | $15.7M | ||
| Q3 24 | $588.9K | $12.3M | ||
| Q2 24 | $2.1M | $11.9M | ||
| Q1 24 | $9.4M | $6.6M |
| Q4 25 | $2.6M | — | ||
| Q3 25 | $2.6M | — | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $11.6M | $37.0M | ||
| Q3 25 | $10.1M | $37.0M | ||
| Q2 25 | $11.7M | $30.4M | ||
| Q1 25 | $12.0M | $31.5M | ||
| Q4 24 | $10.9M | $32.6M | ||
| Q3 24 | $11.2M | $29.1M | ||
| Q2 24 | $10.5M | $23.5M | ||
| Q1 24 | $13.3M | $20.6M |
| Q4 25 | $75.4M | $57.1M | ||
| Q3 25 | $73.3M | $57.5M | ||
| Q2 25 | $77.4M | $52.6M | ||
| Q1 25 | $82.7M | $54.0M | ||
| Q4 24 | $82.7M | $59.2M | ||
| Q3 24 | $82.1M | $57.1M | ||
| Q2 24 | $82.4M | $53.0M | ||
| Q1 24 | $44.2M | $50.7M |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | $2.3M | ||
| Q3 25 | $1.1M | $-1.3M | ||
| Q2 25 | $-1.6M | $1.8M | ||
| Q1 25 | $1.7M | $-3.5M | ||
| Q4 24 | $1.1M | $865.0K | ||
| Q3 24 | $3.6M | $4.3M | ||
| Q2 24 | $-2.6M | $1.4M | ||
| Q1 24 | $-1.4M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.66× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.12× | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
